PRIMARY INTRAOCULAR LYMPHOMA

Clinical trials for PRIMARY INTRAOCULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY INTRAOCULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for PRIMARY INTRAOCULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a Triple-Drug attack stop eye lymphoma in its tracks?

Disease control Recruiting now

This phase II trial is testing a combination of three drugs—zanubrutinib, rituximab, and methotrexate—given through the vein and directly into the eye, for people newly diagnosed with primary intraocular lymphoma, a rare cancer of the eye. The goal is to see if this regimen can i…

Matched conditions: PRIMARY INTRAOCULAR LYMPHOMA

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

PRIMARY INTRAOCULAR LYMPHOMA

Get alerted when new PRIMARY INTRAOCULAR LYMPHOMA trials appear

Can a Triple-Drug attack stop eye lymphoma in its tracks?